Oncology Letters · 2019 · 26 citations · 31 references
MedicineImmunologyOncologyCancer ImmunologyChemotherapyClinical NutritionCancer Survival AnalysisEsophageal CancerImmuno-oncology BiomarkersImmunonutrition In Clinical CareNutrition During Cancer CareOncology NutritionCancer-associated ImmunonutritionCancer-related MalnutritionLeukocyte CountsNutrition During ChemotherapyNutrition For Gastrointestinal CancerNutritional Assessment In CancerNutritional Support After EsophagectomyPsoas Muscle Area
It has been reported that immuno-inflammatory and nutritional parameters are associated with long-term survival in various malignancies. However, little is known regarding the associations between alterations of these parameters during neoadjuvant chemotherapy (NAC) and the response to NAC in patients with esophageal cancer. The present study examined the clinical significance of alterations in these parameters during NAC in terms of the response to NAC and the long-term outcomes in patients with esophageal cancer. Various systemic immuno-inflammatory and nutritional measures including the systemic neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), C-reactive protein (CRP)-to-albumin ratio (CAR) and psoas muscle index (PMI) were examined before and after NAC. Statistical analyses were performed to determine the significance of immuno-inflammatory and nutritional parameters prior to NAC and alterations during NAC regarding the response to NAC and long-term outcomes. The NLR, PMI, neutrophil count and platelet count declined significantly following NAC, whereas no alterations in PLR, CAR, lymphocyte counts, CRP levels and albumin concentration were observed. The decreases in NLR and neutrophil counts following NAC were strongly associated with a favorable overall survival (P=0.006). In conclusion, decreases in NLR and neutrophil counts following NAC were clinically significant predictors of the response to NAC and of survival in esophageal cancer, respectively.
31
Estimates of the worldwide mortality from 25 cancers in 1990
Paola Pisani, Donald Maxwell Parkin, Freddie Bray et al. · International Journal of Cancer · 1999 · 1.5K citations · Full text
Nobutoshi Ando, Hoichi Kato, Hiroyasu Igaki et al. · Annals of Surgical Oncology · 2011 · 1.4K citations
TNM: CLASSIFICATION OF MALIGNANT TUMOURS
The Medical Journal of Australia · 1969 · 1.4K citations
Freddie Bray, Jacques Ferlay, Mathieu Laversanne et al. · International Journal of Cancer · 2015 · 651 citations · Full text
Medicine, Oncology, Cancer Control +16